|
Market Cap (3-Jul) $356,619,552 (530th) |
Close (30-Jun) $0.315 |
Volume (30-Jun) 2,012,212 |
Shortsold (19-Jun) 27,150,697 (1.86%) (138th) |
|
52w High $0.415 |
52w Low $0.223 |
P/E 7.50 |
EPS -0.03 |
IMM released this announcement to the ASX on 21 September 2022, 9:09. The announcement is not marked as price sensitive, and is 1 page(s) in length and 207.65kb in size.
You can view all announcements from IMM and see how they appear on a price chart on the announcements page.
At the date of this announcement, IMM was 0.824% short sold according to ASIC data. It was ranked the 238th most shorted stock on the ASX. It is now ranked as the 138th most shorted stock on the ASX with 1.859% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from IMM | |
|---|---|
| Application for quotation of securities - IMM | 29 June 2023, 10:09 |
| US patent granted for Efti with PD-1 pathway inhibitor | 27 June 2023, 14:37 |
| Immutep completes underwritten retail entitlement offer | 27 June 2023, 8:16 |
| 2022 AGM & Key Dates | 21 September 2022, 9:09 |
| Clinical Development Update for Eftilagimod Alpha | 14 September 2022, 8:14 |
| Initial Director's Interest Notice - Frederic Triebel | 13 September 2022, 8:15 |
| Immutep Appoints LAG-3 Pioneer Dr Frederic Triebel to Board | 13 September 2022, 8:14 |
You must be logged in to post a reply.
